Lysoway Therapeutics
PrivateLast Round
Grant
Aug 5, 2025
Total Funding Raised
$24.93M
Momentum Score
25 /100
Company Overview
Lysoway Therapeutics is a biopharmaceutical company that develops small-molecule modulators of lysosomal ion channels to treat neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B2C
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lysoway Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Lysoway Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 5, 2025 | ||||
| Grant | Jan 5, 2023 | ||||
| Series A | Oct 5, 2022 |
Key People
Founding team and executive leadership
Lysoway Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HighLight Capital | Series A |
| Bencao Capital | Series A |
| Oceanpine Capital | Series A |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| The Silverstein Foundation for Parkinson's with GBA | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 5, 2025
Secured $2.93M in grant funding.
Lysoway Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Lysoway Therapeutics's valuation, stock price, and market status.
